Influence of allergy in patients with nasal polyposis after endoscopic sinus surgery.
CONCLUSIONS
Allergy does not modify the symptoms and steroid consumption (oral and local) of nasal polyposis (NP) patients after functional endoscopic sinus surgery (FESS).


OBJECTIVE
To assess the role of allergy in the evolution after FESS of patients presenting with the diagnosis of NP.


METHODS
This was a prospective study of 63 consecutive patients with NP (57% males, mean age 45.8 years), who were analyzed to detect whether the results of a surgical treatment of NP were influenced by the presence of positive allergic tests (Phadiatop). Three nasal criteria were scored: nasal obstruction, posterior rhinorrhea, and the loss of smell. The frequency of asthma was evaluated. Medical treatment of NP after FESS consisted of washing of the nasal cavities, steroid spray, and oral steroid administration. The amount of consumption of steroids (prednisolone and beclomethasone) was studied.


RESULTS
Decrease of all nasal symptoms was not statistically different in the two groups of patients with and without allergy. Cumulative consumption of prednisolone and beclomethasone after surgery was similar in the two groups.
Bonfils
Pierre
P
Department of ENT-Head and Neck Surgery, European Hospital Georges Pompidou Faculty of Medicine, University Paris-Descartes, Paris, France. pierre.bonfils@egp.aphp.fr
Malinvaud
David
D
D000328:Adult; D001249:Asthma / Q000175:diagnosis; D001507:Beclomethasone / Q000627:therapeutic use; D016535:Bronchial Hyperreactivity / Q000175:diagnosis / Q000453:epidemiology; D001985:Bronchial Provocation Tests; D003131:Combined Modality Therapy; D003430:Cross-Sectional Studies; D004724:Endoscopy; D015521:Ethmoid Sinusitis / Q000453:epidemiology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015508:Nasal Obstruction / Q000175:diagnosis* / Q000453:epidemiology; D009298:Nasal Polyps / Q000175:diagnosis* / Q000453:epidemiology / Q000601:surgery*; D000857:Olfaction Disorders / Q000175:diagnosis* / Q000453:epidemiology; D011183:Postoperative Complications / Q000175:diagnosis* / Q000453:epidemiology; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence; D012130:Respiratory Hypersensitivity / Q000175:diagnosis* / Q000453:epidemiology
D011239:Prednisolone; D001507:Beclomethasone